The University of Chicago Header Logo

Connection

Ayman Al-Hendy to Adenoviridae

This is a "connection" page, showing publications Ayman Al-Hendy has written about Adenoviridae.
Connection Strength

4.651
  1. Targeted Adenoviral Vector Demonstrates Enhanced Efficacy for In Vivo Gene Therapy of Uterine Leiomyoma. Reprod Sci. 2016 Apr; 23(4):464-74.
    View in: PubMed
    Score: 0.502
  2. Enhancing Adenoviral-Mediated Gene Transfer and Expression to Endometrial Cells. Reprod Sci. 2016 08; 23(8):1109-15.
    View in: PubMed
    Score: 0.502
  3. Towards gene therapy of postoperative adhesions: fiber and transcriptional modifications enhance adenovirus targeting towards human adhesion cells. Gynecol Obstet Invest. 2013; 76(2):119-24.
    View in: PubMed
    Score: 0.421
  4. Towards fibroid gene therapy: adenovirus-mediated delivery of herpes simplex virus 1 thymidine kinase gene/ganciclovir shrinks uterine leiomyoma in the Eker rat model. Gynecol Obstet Invest. 2009; 68(1):19-32.
    View in: PubMed
    Score: 0.312
  5. Gene therapy targeting leiomyoma: adenovirus-mediated delivery of dominant-negative estrogen receptor gene shrinks uterine tumors in Eker rat model. Fertil Steril. 2010 Jan; 93(1):239-50.
    View in: PubMed
    Score: 0.307
  6. Toward gene therapy of endometriosis: transductional and transcriptional targeting of adenoviral vectors to endometriosis cells. Am J Obstet Gynecol. 2008 Aug; 199(2):117.e1-6.
    View in: PubMed
    Score: 0.298
  7. Toward gene therapy of uterine fibroids: targeting modified adenovirus to human leiomyoma cells. Hum Reprod. 2008 Mar; 23(3):514-24.
    View in: PubMed
    Score: 0.286
  8. Toward gene therapy of primary ovarian failure: adenovirus expressing human FSH receptor corrects the Finnish C566T mutation. Mol Hum Reprod. 2008 Jan; 14(1):9-15.
    View in: PubMed
    Score: 0.285
  9. Toward gene therapy of endometriosis: adenovirus-mediated delivery of dominant negative estrogen receptor genes inhibits cell proliferation, reduces cytokine production, and induces apoptosis of endometriotic cells. Fertil Steril. 2007 Aug; 88(2):462-71.
    View in: PubMed
    Score: 0.270
  10. Gene therapy of uterine leiomyoma: adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir treatment inhibits growth of human and rat leiomyoma cells in vitro and in a nude mouse model. Gynecol Obstet Invest. 2007; 63(2):61-70.
    View in: PubMed
    Score: 0.261
  11. Molecular Bio-Imaging Probe for Non-Invasive Differentiation Between Human Leiomyoma Versus Leiomyosarcoma. Reprod Sci. 2020 02; 27(2):644-654.
    View in: PubMed
    Score: 0.165
  12. Modified Adenovirus Reduces De Novo Peritoneal Adhesions in Rats and Limits Off-Target Transfection. Role of EZH2 in Adhesion Formation. J Invest Surg. 2017 Apr; 30(2):78-87.
    View in: PubMed
    Score: 0.131
  13. Magnetic nanoparticles as a new approach to improve the efficacy of gene therapy against differentiated human uterine fibroid cells and tumor-initiating stem cells. Fertil Steril. 2016 06; 105(6):1638-1648.e8.
    View in: PubMed
    Score: 0.126
  14. Targeting adenoviral vectors for enhanced gene therapy of uterine leiomyomas. Hum Reprod. 2013 Sep; 28(9):2398-406.
    View in: PubMed
    Score: 0.105
  15. Toward gene therapy of premature ovarian failure: intraovarian injection of adenovirus expressing human FSH receptor restores folliculogenesis in FSHR(-/-) FORKO mice. Mol Hum Reprod. 2010 Apr; 16(4):241-50.
    View in: PubMed
    Score: 0.082
  16. Adenovirus-mediated overexpression of human tissue plasminogen activator prevents peritoneal adhesion formation/reformation in rats. Surgery. 2009 Jul; 146(1):12-7.
    View in: PubMed
    Score: 0.079
  17. Low-dose simultaneous delivery of adenovirus encoding hepatocyte growth factor and vascular endothelial growth factor in dogs enhances liver proliferation without systemic growth factor elevation. Liver Int. 2009 Aug; 29(7):1022-30.
    View in: PubMed
    Score: 0.079
  18. Memy I: a novel murine model for uterine leiomyoma using adenovirus-enhanced human fibroid explants in severe combined immune deficiency mice. Am J Obstet Gynecol. 2008 Aug; 199(2):156.e1-8.
    View in: PubMed
    Score: 0.073
  19. Adenovirus-mediated delivery of a dominant-negative estrogen receptor gene in uterine leiomyoma cells abrogates estrogen- and progesterone-regulated gene expression. J Clin Endocrinol Metab. 2007 Oct; 92(10):3949-57.
    View in: PubMed
    Score: 0.069
  20. Adenovirus-mediated expression of cyclooxygenase-2 antisense reverse abnormal genetic profile of human adhesion fibroblasts. Fertil Steril. 2008 May; 89(5 Suppl):1455-60.
    View in: PubMed
    Score: 0.069
  21. Inhibition of growth of cervical cancer cells using a dominant negative estrogen receptor gene. Gynecol Oncol. 2007 Feb; 104(2):276-80.
    View in: PubMed
    Score: 0.066
  22. Gene therapy of uterine leiomyomas: adenovirus-mediated expression of dominant negative estrogen receptor inhibits tumor growth in nude mice. Am J Obstet Gynecol. 2004 Nov; 191(5):1621-31.
    View in: PubMed
    Score: 0.057
  23. Ovarian cancer gene therapy: repeated treatment with thymidine kinase in an adenovirus vector and ganciclovir improves survival in a novel immunocompetent murine model. Am J Obstet Gynecol. 2000 Mar; 182(3):553-9.
    View in: PubMed
    Score: 0.042
  24. Applying the herpes simplex virus thymidine kinase/ganciclovir approach to ovarian cancer: an effective in vitro drug-sensitization system. Gynecol Obstet Invest. 1997; 43(4):268-75.
    View in: PubMed
    Score: 0.033
  25. Mutant MMP-9 and HGF gene transfer enhance resolution of CCl4-induced liver fibrosis in rats: role of ASH1 and EZH2 methyltransferases repression. PLoS One. 2014; 9(11):e112384.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.